You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ROCEPHIN Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Rocephin, and when can generic versions of Rocephin launch?

Rocephin is a drug marketed by Hoffmann La Roche and Roche and is included in five NDAs.

The generic ingredient in ROCEPHIN is ceftriaxone sodium; lidocaine. There are twenty-six drug master file entries for this compound. Additional details are available on the ceftriaxone sodium; lidocaine profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for ROCEPHIN?
  • What are the global sales for ROCEPHIN?
  • What is Average Wholesale Price for ROCEPHIN?
Summary for ROCEPHIN
Drug patent expirations by year for ROCEPHIN
Recent Clinical Trials for ROCEPHIN

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Melbourne HealthPhase 3
University of MalayaPhase 3
Changi General HospitalPhase 3

See all ROCEPHIN clinical trials

US Patents and Regulatory Information for ROCEPHIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 062654-002 Apr 30, 1987 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN W/ DEXTROSE IN PLASTIC CONTAINER ceftriaxone sodium INJECTABLE;INJECTION 050624-002 Feb 11, 1987 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 063239-002 Aug 13, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INJECTION 050585-005 Dec 21, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Hoffmann La Roche ROCEPHIN ceftriaxone sodium INJECTABLE;INTRAMUSCULAR, INTRAVENOUS 050585-004 Dec 21, 1984 DISCN Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.